Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU, UK
MAXALT 5 mg Tablets.
MAXALT 10 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. MAXALT 5 mg tablets: 5 mg tablets are pale pink, capsule shaped, coded MSD on one side and 266 on the other. MAXALT 10 mg tablets: 10 mg tablets are pale pink, capsule-shaped, coded MAXALT on one side and MSD 267 on the other. |
Each tablet contains 7.265 mg of rizatriptan benzoate (corresponding to 5 mg of the rizatriptan).
Excipient(s) with known effect: Lactose monohydrate 30.25 mg in the 5 mg tablet.
Each tablet contains 14.53 mg of rizatriptan benzoate (corresponding to 10 mg of the rizatriptan).
Excipient(s) with known effect: Lactose monohydrate 60.5 mg in the 10 mg tablet.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Rizatriptan |
Rizatriptan binds selectively with high affinity to human 5-HT1B and 5-HT1D receptors. The therapeutic activity of rizatriptan in treating migraine headache may be attributed to its agonist effects at 5-HT1B and 5-HT1D receptors on the extracerebral intracranial blood vessels that are thought to become dilated during an attack and on the trigeminal sensory nerves that innervate them. |
| List of Excipients |
|---|
|
Lactose monohydrate |
All aluminium blister push through, packs of 2, 3, 6, 12 or 18 tablets.
Not all pack sizes may be marketed.
Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU, UK
Tablet 5 mg: PL 00025/0369
Tablet 10 mg: PL 00025/0370
Date of first authorisation: June 1998
Date of latest renewal: 12 May 2014
| Drug | Countries | |
|---|---|---|
| MAXALT | Austria, Australia, Brazil, Canada, Germany, Estonia, Spain, Finland, France, Croatia, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
